S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Sports analytics may be outnumbered when it comes to artificial intelligence
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Sports analytics may be outnumbered when it comes to artificial intelligence
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Sports analytics may be outnumbered when it comes to artificial intelligence
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Sports analytics may be outnumbered when it comes to artificial intelligence
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway

Viveve Medical (VIVE) Competitors

$0.0002
0.00 (0.00%)
(As of 03/1/2024 ET)

VIVE vs. NOVNQ, ONCSQ, KLDO, GNCA, NBRV, VRAYQ, TIVC, NUWE, HSDT, and BSGM

Should you be buying Viveve Medical stock or one of its competitors? The main competitors of Viveve Medical include NVN Liquidation (NOVNQ), OncoSec Medical (ONCSQ), Kaleido Biosciences (KLDO), Genocea Biosciences (GNCA), Nabriva Therapeutics (NBRV), ViewRay (VRAYQ), Tivic Health Systems (TIVC), Nuwellis (NUWE), Helius Medical Technologies (HSDT), and BioSig Technologies (BSGM). These companies are all part of the "medical" sector.

Viveve Medical vs.

Viveve Medical (NASDAQ:VIVE) and NVN Liquidation (NASDAQ:NOVNQ) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, community ranking, risk, dividends, institutional ownership, media sentiment, profitability and analyst recommendations.

Viveve Medical received 311 more outperform votes than NVN Liquidation when rated by MarketBeat users.

CompanyUnderperformOutperform
Viveve MedicalOutperform Votes
311
73.70%
Underperform Votes
111
26.30%
NVN LiquidationN/AN/A

Company Net Margins Return on Equity Return on Assets
Viveve MedicalN/A N/A N/A
NVN Liquidation N/A N/A N/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Viveve Medical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
NVN Liquidation
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

7.1% of NVN Liquidation shares are held by institutional investors. 5.7% of Viveve Medical shares are held by insiders. Comparatively, 1.3% of NVN Liquidation shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, NVN Liquidation had 1 more articles in the media than Viveve Medical. MarketBeat recorded 1 mentions for NVN Liquidation and 0 mentions for Viveve Medical. NVN Liquidation's average media sentiment score of 1.02 beat Viveve Medical's score of 0.00 indicating that NVN Liquidation is being referred to more favorably in the news media.

Company Overall Sentiment
Viveve Medical Neutral
NVN Liquidation Positive

Viveve Medical has higher earnings, but lower revenue than NVN Liquidation.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Viveve Medical$6.43M0.00-$22.03MN/AN/A
NVN Liquidation$23.68M0.00-$31.31M-$1.320.00

Viveve Medical has a beta of 0.06, indicating that its stock price is 94% less volatile than the S&P 500. Comparatively, NVN Liquidation has a beta of 0.02, indicating that its stock price is 98% less volatile than the S&P 500.

Summary

NVN Liquidation beats Viveve Medical on 5 of the 9 factors compared between the two stocks.


Get Viveve Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for VIVE and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VIVE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VIVE vs. The Competition

MetricViveve MedicalElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$2,000.00$3.38B$5.21B$7.62B
Dividend YieldN/A1.71%2.82%3.87%
P/E RatioN/A15.31257.3718.81
Price / Sales0.0074.153,092.04110.41
Price / CashN/A49.3699.8655.35
Price / BookN/A4.154.534.54
Net Income-$22.03M$95.15M$114.95M$211.55M
7 Day PerformanceN/A2.99%5.72%3.36%
1 Month PerformanceN/A8.25%12.81%6.68%
1 Year PerformanceN/A42.43%12.92%8.85%

Viveve Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NOVNQ
NVN Liquidation
0 of 5 stars
N/AN/AN/A$3,000.00$23.68M0.0090News Coverage
High Trading Volume
ONCSQ
OncoSec Medical
0 of 5 stars
N/AN/AN/A$1,000.00N/A0.0040Gap Down
High Trading Volume
KLDO
Kaleido Biosciences
0 of 5 stars
N/AN/AN/A$4,000.00$1.10M0.0076
GNCA
Genocea Biosciences
0 of 5 stars
N/AN/AN/A$6,000.00$1.91M0.0074Analyst Report
NBRV
Nabriva Therapeutics
0 of 5 stars
$0.00
flat
N/AN/A$6,000.00$35.59M0.0039Analyst Report
News Coverage
VRAYQ
ViewRay
0 of 5 stars
N/AN/AN/A$18,000.00$102.21M0.00295
TIVC
Tivic Health Systems
0 of 5 stars
$1.24
flat
N/A-93.8%$1.82M$1.23M-0.0316Short Interest ↑
Gap Down
NUWE
Nuwellis
0.3535 of 5 stars
$0.70
+16.6%
N/A-92.7%$2.29M$8.54M-0.0470Upcoming Earnings
Short Interest ↑
Gap Up
High Trading Volume
HSDT
Helius Medical Technologies
1.1707 of 5 stars
$5.83
-0.2%
$85.00
+1,358.0%
-68.5%$4.14M$790,000.00-0.2726Short Interest ↑
Gap Up
BSGM
BioSig Technologies
0 of 5 stars
$0.52
-16.1%
N/A-93.1%$4.69M$290,000.00-0.1147Short Interest ↑
Gap Up
High Trading Volume

Related Companies and Tools

This page (NASDAQ:VIVE) was last updated on 3/3/2024 by MarketBeat.com Staff